FDA Approved Therapy for SOD1 Associated ALS - podcast episode cover

FDA Approved Therapy for SOD1 Associated ALS

May 18, 202319 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.

Read the related article on the FDA website.

Disclosures can be found at Neurology.org

For the best experience, listen in Metacast app for iOS or Android